Rescue Paracetamol in Postoperative Pain Management in Extremely Low Birth Weight Neonates Following Abdominal Surgery: A Single Unit Retrospective Study

. 2022 ; 10 () : 895040. [epub] 20220623

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid35813372

BACKGROUND: Intravenous paracetamol added to morphine reduces postoperative morphine consumption in (near)term neonates. However, there are only sparse data on intravenous paracetamol as multimodal strategy in extremely low birth weight (ELBW) neonates. OBJECTIVES: This study aims to assess the effects of rescue intravenous paracetamol on postoperative pain management (≤48 h postoperatively) in relation to both analgesic efficacy (validated pain assessment, drug consumption, adequate rescue medication) and safety (hypotension and bradycardia). This rescue practice was part of a standardized pain management approach in a single neonatal intensive care unit (NICU). METHODS: A single-center retrospective observational study included 20 ELBW neonates, who underwent major abdominal surgery. The primary endpoints of the postoperative study period were pain intensity, over-sedation, time to first rescue analgesic dose, and the effect of paracetamol on opiate consumption. Secondary endpoints were safety parameters (hypotension, bradycardia). And as tertiary endpoints, the determinants of long-term outcome were evaluated (i.e., duration of mechanical ventilation, intraventricular hemorrhage - IVH, periventricular leukomalacia - PVL, postnatal growth restriction, stage of chronic lung disease - CLD or neurodevelopmental outcome according to Bayley-II Scales of Infant Development at 18-24 months). RESULTS: All neonates received continuous opioids (sufentanil or morphine) and 13/20 also intravenous paracetamol as rescue pain medication during a 48-h postoperative period. Although opioid consumption was equal in the non-paracetamol and the paracetamol group over 48 h, the non-paracetamol group was characterized by oversedation (COMFORTneo < 9), a higher incidence of severe hypotension, and younger postnatal age (p < 0.05). All long-term outcome findings were similar between both groups. CONCLUSIONS: Our study focused on postoperative pain management in ELBW neonates, and showed that intravenous paracetamol seems to be safe. Prospective validation of dosage regimens of analgesic drugs is needed to achieve efficacy goals.

Zobrazit více v PubMed

Harris J, Ramelet AS, van Dijk M, Pokorna P, Wielenga J, Tume L, et al. . Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med. (2016) 42:972–86. 10.1007/s00134-016-4344-1 PubMed DOI PMC

Pokorna P, Tibboel D. Numbers, numbers: great, greatbut?! Pediatr Crit Care Med. (2020) 21:844–5. 10.1097/PCC.0000000000002371 PubMed DOI

Hatfield L. Neonatal pain: what′s age got to do with it? Surg Neurol Int. (2014) 5:479. 10.4103/2152-7806.144630 PubMed DOI PMC

Walker SM. Long-term effects of neonatal pain. Semin Fetal Neonatal Med. (2019) 24:101005. 10.1016/j.siny.2019.04.005 PubMed DOI

Allegaert K, van den Anker J. Sedation in the neonatal intensive care unit: international practice. In: Mason KP, editor. Pediatric Sedation Outside of the Operating Room. Cham: Springer International Publishing; (2021). p. 305–43. 10.1007/978-3-030-58406-1_18 DOI

McPherson C, Miller SP, El-Dib M, Massaro AN, Inder TE. The influence of pain, agitation, and their management on the immature brain. Pediatr Res. (2020) 88:168–75. 10.1038/s41390-019-0744-6 PubMed DOI PMC

Williams MD, Lascelles BDX. Early neonatal pain—a review of clinical and experimental implications on painful conditions later in life. Front Pediatr. (2020) 8:e00030 10.3389/fped.2020.00030 PubMed DOI PMC

Brummelte S, Grunau RE, Chau V, Poskitt KJ, Brant R, Vinall J, et al. . Procedural pain and brain development in premature newborns. Ann Neurol. (2012) 71:385–96. 10.1002/ana.22267 PubMed DOI PMC

Ranger M, Grunau RE. Early repetitive pain in preterm infants in relation to the developing brain. Pain Manag. (2014) 4:57–67. 10.2217/pmt.13.61 PubMed DOI PMC

Munsters J, Wallstróm L, Ågren J, Norsted T, Sindelar R. Skin conductance measurements as pain assessment in newborn infants born at 22-27weeks gestational age at different postnatal age. Early Hum Dev. (2012) 88:21–6. 10.1016/j.earlhumdev.2011.06.010 PubMed DOI

Van Dijk M, Ceelie I, Tibboel D. Endpoints in pediatric pain studies. Eur J Clin Pharmacol. (2011) 67:61–6. 10.1007/s00228-010-0947-6 PubMed DOI PMC

FDA-M CERSI: Analgesic Clinical Trial Designs, Extrapolation, and Endpoints in Patients from Birth to Less Than Two Years of Age Public Workshop. (2021). Available online at: https://www.fda.gov/drugs/news-events-human-drugs/fda-m-cersi-analgesic-clinical-trial-designs-extrapolation-and-endpoints-patients-birth-less-two (accessed May 28, 2022).

Giordano V, Edobor J, Deindl P, Wildner B, Goeral K, Steinbauer P, et al. . Pain and sedation scales for neonatal and pediatric patients in a preverbal stage of development: a systematic review. JAMA Pediatr. (2019) 173:1186–97. 10.1001/jamapediatrics.2019.3351 PubMed DOI

Simons SHP, van den Bosch GE, Tibboel D. Analgesic agents and sedatives. In: Aranda JV. editor. Neonatal and Pediatric pharmacology, Therapeutic Principles in Practice. Philadelphia: Lippincott Williams & Wilkins; (2021). p. 972.

Ceelie I, De Wildt SN, Van Dijk M, Van Den Berg MMJ, Van Den Bosch GE, Duivenvoorden HJ, et al. . Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery: a randomized controlled trial. JAMA J Am Med Assoc. (2013) 309:149–54. 10.1001/jama.2012.148050 PubMed DOI

ten Barge JA, Vermeulen MJ, Simons SHP, van den Bosch GE. Pain management for necrotizing enterocolitis: getting the balance right. Pediatr Res. (2022) 1–9. 10.1038/s41390-022-01968-2 PubMed DOI PMC

Van Dijk M, Roofthooft DWE, Anand KJS, Guldemond F, De Graaf J, Simons S, et al. . Taking up the challenge of measuring prolonged pain in (premature) neonates the COMFORTneo scale seems promising. Clin J Pain. (2009) 25:607–16. 10.1097/AJP.0b013e3181a5b52a PubMed DOI

Ziesenitz VC, Vaughns JD, Koch G, Mikus G, van den Anker JN. Pharmacokinetics of fentanyl and its derivatives in children: a comprehensive review. Clin Pharmacokinet. (2018) 57:125–49. 10.1007/s40262-017-0569-6 PubMed DOI PMC

Pokorná P, Šíma M, Koch B, Tibboel D, Slanar O. Sufentanil disposition and pharmacokinetic model-based dosage regimen for sufentanil in ventilated full-term neonates. Pharmacology. (2021) 106:384–9. 10.1159/000515787 PubMed DOI

Micormedex NeoFax Essentials . (2014). Available online at: https://www.micromedexsolutions.com (accessed February 5, 2022).

Arnold R, Weissman DE. Calculating opioid dose conversions #36. J Palliat Med. (2003) 6:619–20. 10.1089/109662103768253731 PubMed DOI

Soreze Y, Audureau E, Decobert F, Jaby O, Blary S, Danan C, et al. . Reduced sufentanil doses are effective for postoperative analgesia after ductal closure in extremely premature infants: a 10 years retrospective cohort study. Clin J Pain. (2017) 33:1109–16. 10.1097/AJP.0000000000000487 PubMed DOI

Slater R, Cantarella A, Gallella S, Worley A, Boyd S, Meek J, et al. . Cortical pain responses in human infants. J Neurosci. (2006) 26:3662–6. 10.1523/JNEUROSCI.0348-06.2006 PubMed DOI PMC

Knibbe CAJ, Krekels EHJ, Van Den Anker JN, DeJongh J, Santen GWE, Van Dijk M, et al. . Morphine glucuronidation in preterm neonates, infants and children younger than 3 years. Clin Pharmacokinet. (2009) 48:371–85. 10.2165/00003088-200948060-00003 PubMed DOI

Krekels EHJ, Tibboel D, De Wildt SN, Ceelie I, Dahan A, Van Dijk M, et al. . Evidence-based morphine dosing for postoperative neonates and infants. Clin Pharmacokinet. (2014) 53:553–63. 10.1007/s40262-014-0135-4 PubMed DOI

Greeley WJ, De Bruijn NP, Davis DP. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg. (1987) 66:1067–72. 10.1213/00000539-198711000-00001 PubMed DOI

Thigpen JC, Odle BL, Harirforoosh S. Opioids: A review of pharmacokinetics and pharmacodynamics in neonates, infants, and children. Eur J Drug Metab Pharmacokinet. (2019) 44:591–609. 10.1007/s13318-019-00552-0 PubMed DOI

van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol. (2018) 58:S10–25. 10.1002/jcph.1284 PubMed DOI

Sanders RD, Hassell J, Davidson AJ, Robertson NJ, Ma D. Impact of anaesthetics and surgery on neurodevelopment: an update. Br J Anaesth. (2013) 110:i53–72. 10.1093/bja/aet054 PubMed DOI PMC

McPherson C, Haslam M, Pineda R, Rogers C, Neil JJ, Inder TE. Brain injury and development in preterm infants exposed to fentanyl. Ann Pharmacother. (2015) 49:1291–7. 10.1177/1060028015606732 PubMed DOI PMC

De Graaf J, Van Lingen RA, Valkenburg AJ, Weisglas-Kuperus N, Groot Jebbink L, Wijnberg-Williams B, et al. . Does neonatal morphine use affect neuropsychological outcomes at 8 to 9 years of age? Pain. (2013) 154:449–58. 10.1016/j.pain.2012.12.006 PubMed DOI

Zwicker JG, Miller SP, Grunau RE, Chau V, Brant R, Studholme C, et al. . Smaller cerebellar growth and poorer neurodevelopmental outcomes in very preterm infants exposed to neonatal morphine. J Pediatr. (2016) 172:81–7.e2. 10.1016/j.jpeds.2015.12.024 PubMed DOI PMC

Baarslag MA, Allegaert K, Van Den Anker JN, Knibbe CAJ, Van Dijk M, Simons SHP, et al. . Paracetamol and morphine for infant and neonatal pain; still a long way to go? Expert Rev Clin Pharmacol. (2017) 10:111–26. 10.1080/17512433.2017.1254040 PubMed DOI

Howard CR, Howard FM, Weitzman ML. Acetaminophen analgesia in neonatal circumcision: the effect on pain. Pediatrics. (1994) 93:641–6. 10.1542/peds.93.4.641 PubMed DOI

Allegaert K. A critical review on the relevance of paracetamol for procedural pain management in neonates. Front Pediatr. (2020) 8:89. 10.3389/fped.2020.00089 PubMed DOI PMC

Rana D, Bellflower B, Sahni J, Kaplan AJ, Owens NT, El A, et al. . Reduced narcotic and sedative utilization in a NICU after implementation of pain management guidelines. J Perinatol. (2017) 37:1038–42. 10.1038/jp.2017.88 PubMed DOI

Dunbar AE, Sharek PJ, Mickas NA, Coker KL, Duncan J, McLendonf D, et al. . Implementation and case-study results of potentially better practices to improve pain management of neonates. Pediatrics. (2006) 118:S87–94. 10.1542/peds.2006-0913E PubMed DOI

Grabski DF, Vavolizza RD, Lepore S, Levin D, Rasmussen SK, Swanson JR, et al. . A quality improvement intervention to reduce postoperative opiate use in neonates. Pediatrics. (2020) 146:e20193861. 10.1542/peds.2019-3861 PubMed DOI PMC

Härmä A, Aikio O, Hallman M, Saarela T. Intravenous paracetamol decreases requirements of morphine in very preterm infants. J Pediatr. (2016) 168:36–40. 10.1016/j.jpeds.2015.08.003 PubMed DOI

Mian P, Knibbe CAJ, Tibboel Di, Allegaert K. What is the dose of intravenous paracetamol for pain relief in neonates? Arch Dis Child. (2017) 102:649–50. 10.1136/archdischild-2017-312870 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...